Discover-From Scientific Research

The REDUCE-IT study led by Brigham and Women's Hospital can be said to be a milestone in the industry. Studies have shown that in patients already receiving statin therapy but with an increased risk of cardiovascular disease,Reduced the risk of major cardiovascular events by 25%, including a 20% reduction in death from cardiovascular causes and a 20% reduction in the number of heart attacks. The risk was reduced by 31% and the risk of stroke was reduced by 28%.
Based on the results of the REDUCE-IT study, a scientific advisory report published by the American Heart Association (AHA) proposed that for most patients with elevated triglyceride levels (200-499 mg/dL), the use of EPA+DHA or only Prescription Omega-3s containing EPA can effectively reduce triglyceride levels by 20 to 30 percent.
A team of researchers from Harvard Medical School conducted a systematic review of existing clinical trials and presented supporting evidence for common fish oil supplements. After excluding the REDUCE-IT study data, taking Omega-3 supplements significantly reduced the risk of multiple cardiovascular diseases, including an 8% reduction in the risk of myocardial infarction, an 8% reduction in the risk of death from coronary heart disease, and a 5% reduction in the risk of all coronary heart disease,the risk of cardiovascular death was reduced by 7%, and the risk of total cardiovascular disease was reduced by 3%. Only the risk of stroke was not significantly improved.